norcantharidin has been researched along with Angiogenesis, Pathologic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, FY; Chen, XJ; Geng, GQ; Li, ZD; Liu, XS; Liu, YQ; Luo, LL; Sun, SB; Xie, XR; Zhang, XP | 1 |
| Chi, J; Han, B; Jiang, Z; Liu, W; Peng, Y; Qiao, J | 1 |
| Fan, YZ; Ge, CY; Liu, ZY; Lu, XS; Sun, W; Zhang, JT; Zhang, WZ; Zhao, ZM | 1 |
| Fan, YZ; Li, XP; Liu, ZY; Sun, W; Zhang, JT; Zhu, W | 1 |
| Chen, YJ; Ku, KL; Kuo, CD; Liao, HF; Shie, HS; Tsai, YM | 1 |
| Chen, CQ; Fan, YZ; Sun, W; Zhang, JT; Zhao, ZM | 1 |
| Fan, Z; Hou, F; Li, D; Li, Q; Liu, J; Liu, M; Yu, T; Zhou, L | 1 |
| Cai, J; Chen, X; Chen, Z; Ji, Q; Li, Q; Liu, X; Qiu, Y; Sun, J; Zhang, L; Zhu, H | 1 |
| Chen, CQ; Fan, YZ; Sun, W; Zhao, ZM | 1 |
9 other study(ies) available for norcantharidin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Norcantharidin combined with diamminedichloroplatinum inhibits tumor growth and cancerometastasis of hepatic carcinoma in murine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Synergism; Female; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Treatment Outcome | 2018 |
Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system.
Topics: A549 Cells; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carbohydrate Sequence; Carcinoma, Lewis Lung; Cell Movement; Chitosan; Down-Regulation; Drug Carriers; Female; Humans; Lung; Male; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Neovascularization, Pathologic; Solubility; Tissue Inhibitor of Metalloproteinase-1; Vascular Endothelial Growth Factor A | 2019 |
Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gallbladder Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP.
Topics: Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Gallbladder Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Mice; Neovascularization, Pathologic; Tissue Inhibitor of Metalloproteinase-2; Xenograft Model Antitumor Assays | 2015 |
Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Anoikis; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Survival; Chemotaxis; Humans; Infant, Newborn; Kidney; Liver; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A | 2009 |
Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Angiopoietin-2; Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gallbladder Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Magnetic Resonance Angiography; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Perfusion Imaging; Polymerase Chain Reaction; Rats; Regional Blood Flow; Thrombospondins; Time Factors; Tissue Inhibitor of Metalloproteinase-2; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Norcantharidin anti-angiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer.
Topics: Angiogenesis Inhibitors; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Colorectal Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2012 |
Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
Topics: Angiogenesis Inhibitors; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice; Mice, SCID; Neoplasm Invasiveness; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2013 |
[Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
Topics: Angiostatins; Animals; Antimetabolites, Antineoplastic; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Fluorouracil; Gallbladder Neoplasms; Humans; Immunohistochemistry; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinases; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2006 |